These findings suggest that the enhanced anti-P-gp effect of the MTX+4-HC combination compared to MTX alone in RA-FLSs is mediated through the inhibition of the JAK2/STAT3 signaling pathway. This evidence concerns the gene JAK2 and rheumatoid arthritis.